NYU Langone Health acquired the hospital in 2016. The study analyzed outcomes for 181,252 nonpsychiatric, nonrehabilitation and non-newborn patients discharged between Sept. 1, 2010, and Aug. 31, 2019, at the hospital.
The study found fewer central infections per 1,000 catheter days and fewer catheter-associated urinary tract infections per 1,000 discharges. More patients were likely to recommend the hospital after the merger than before.
The study did not find any significant improvements in readmission rates.
“Our study shows that when a hospital merger has a comprehensive strategy, focuses on quality and involves meaningful operational integration, outcomes can be significantly improved at the acquired hospital,” lead study author Erwin C. Wang, MD, said in Jan. 6 news release by NYU Langone Health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
